https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Dental-MS.jpg

Dental Bone Graft Substitutes Market Size, Share & COVID19 Impact Analysis | United States | 2021-2027 | MedSuite | Includes: Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, Synthetic Bone Grafts, Dental Barrier Membranes & Dental Growth Factor Devices

  • Year: 2021
  • Scope: 10 Years
  • Region: United States
  • Published Date: 12/23/21
  • Type: MedSuite

In 2021, the US dental bone graft substitutes (DBGS) market size is expected to reach $390 million, with the Allograft market showing the fastest growth. Despite COVID19, the US market size is expected to increase over the forecast period to exceed $540 million in 2027. Over 40% of the dental bone graft substitutes market share in the US was dominated by three main competitors – Geistlich, Zimmer Biomet, and ACE Surgical.

US Dental Bone Graft Substitute Market Size Growth, 2017-2027

Dental bone graft substitutes market growth in the US will be driven by continued technological developments that allow companies to introduce new products with innovations to increase the ease of use and patient comfort. This research takes a closer look at new product launches, specifically in the innovation-rich segments like the barrier membrane market, to understand the impact on the Average Selling Prices (ASPs) and the overall market value.

A major limiter to growth in the dental bone graft substitute market is the effect of commoditization. The full report further analyzes how product differentiation and device pricing decisions in the market are affected by supply chain characteristics and by the market penetration of small competitors.

DATA TYPES INCLUDED IN THIS STUDY

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Dental Bone Grafting Procedure Volumes
  • Market Forecasts Until 2027 & Historical Data to 2017
  • Competitive Analysis with Market Shares for Each Market Segment
  • Market Drivers & Limiters
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the DBGS Market in the US
  • Disease Overviews & Demographic Information
  • Company Profiles, Product Portfolios & SWOT for Top Competitors

COVID19 Impact On Dental Bone Graft Substitutes Market

Due to elective procedure cancellations, the US dental bone graft substitutes market decreased by around 21% in 2020 when compared to 2019. Following the closure of non-essential businesses (including elective dental surgeries) in Q1 and much of Q2 2020, the dental implant and bone graft substitute markets began to show strong signs of recovery in Q3 as dentists began working through the backlog of pent-up demand.

Most dental practices and supply companies are estimated to end 2020 with an approximately 20% decrease in revenue over the previous year. Overall, the US dental bone graft substitutes market is expected to fully recover in late 2021 / early 2022.

Competitive Market Share Insights

In 2020, over 40% of the US dental bone graft substitutes market was controlled by three main competitors – Geistlich, Zimmer Biomet, and ACE Surgical.

US Dental Bone Graft Substitute Market Share Leaders

Geistlich was the leader of the DBGS market in the U.S. in 2020. This market study provides detailed information on main product lines and key segments that result in the company’s prominence in the overall market.

Zimmer Biomet fell to the second-place position in the US market for dental bone graft substitutes. The company was formed through the merger of Zimmer and Biomet in June 2015, combining the dental divisions of each company, Zimmer Dental, and BIOMET 3i. Zimmer Biomet is expected to maintain a strong presence in the DBGS market and its market presence is analyzed in detail along with its main product lines and sub-segments of presence.

In 2020, ACE Surgical was the third-leading competitor in the US dental bone graft substitutes market. The company offers products in both the mineralized allograft and xenograft DBGS segments. ACE Surgical has a unique presence in the US market which is analyzed in detail in this report’s competitive analysis section.

Market Segmentation Summary

While this MedSuite report contains all the market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

  • Dental Bone Grafting Procedure Numbers | United States | 2021-2027 | MedPro – Using several databases, internal and external, we’re able to provide the volume of dental bone grafting procedures being performed in the US, including dental implant and periodontal procedures performed using bone graft substitutes.
  • Dental Bone Graft Substitute Market | United States | 2021-2027 | MedCore – The market analysis is further broken down into segments, such as Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, and Synthetic Bone Grafts.
  • Dental Barrier Membrane Market | United States | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
    • Device Type: Resorbable and Non-Resorbable Dental Barrier Membranes;
    • Material Type: Xenograft, Synthetic, and Allograft.
  • Dental Growth Factor Market | United States | 2021-2027 | MedCore – The market analysis is also further segmented by:
    • Device Type: Emdogain®, GEM 21S®, Infuse™, and Osteocel® devices.

Top US DBGS Companies Analyzed

  • AB Dental
  • ACE Surgical
  • Benco
  • Bicon
  • BioHorizons
  • BioMimetic
  • Botiss Biomaterials
  • BTI
  • Collagen Matrix
  • Cortex Dental
  • Curasan
  • Datum Dental
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Envista
  • Exactech
  • Geistlich
  • Halma
  • Henry Schein
  • Impladent LTD
  • Implant Direct
  • Inion
  • KaVo Kerr
  • Keystone Dental
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Medtronic
  • MegaGen
  • Nobel Biocare
  • Osteogenics Biomedical
  • Osteohealth
  • Patterson
  • Regentix
  • Salvin
  • Snoasis Medical
  • Straumann Group
  • Tissue Banks
  • Unicare Biomedical
  • Zimmer Biomet

FREE Sample Report

 

TABLE OF CONTENTS I

LIST OF FIGURES VII
LIST OF CHARTS X
EXECUTIVE SUMMARY 1
U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
KEY REPORT UPDATES 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
Step 1: Project Initiation & Team Selection 9
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22
IMPACT OF COVID-19 ON THE U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET 23
2.1 INTRODUCTION 23
2.2 MULTI-SCENARIO ANALYSIS 25
2.2.1.1 Best Case Scenario 25
2.2.1.2 Base Case Scenario 26
2.2.1.3 Worst Case Scenario 27
DISEASE OVERVIEW 29
3.1 BASIC ANATOMY 29
3.1.1 Dental Anatomy: Oral Cavity and Intraoral Landmarks 29
3.2 DISEASE PATHOLOGY AND DISORDERS 30
3.2.1 General Diagnostics 30
3.2.2 Indication for Dental Implant 30
3.2.3 Periodontal Disease 31
3.2.4 Dental Implant Procedures 32
3.2.5 Guided Bone Regeneration 33
3.3 PATIENT DEMOGRAPHICS 34
3.3.1 General Dental Statistics 34
3.3.2 Tooth Loss Statistics 35
PRODUCT ASSESSMENT 37
4.1 INTRODUCTION 37
4.2 PRODUCT PORTFOLIOS 37
4.2.1 Dental Bone Graft Substitutes 37
4.2.1.1 Allografts 38
4.2.1.1.1 Mineralized Allografts 38
4.2.1.1.2 Demineralized Bone Matrix 38
4.2.1.2 Autografts 39
4.2.1.3 Synthetics 40
4.2.1.4 Xenografts 41
4.2.2 Dental Growth Factors 44
4.2.3 Dental Barrier Membrane 45
4.3 REGULATORY ISSUES AND RECALLS 47
4.3.1 Geistlich 47
4.4 CLINICAL TRIALS 48
4.4.1 Dental Grafts 48
U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.1.1 Applications of Dental Bone Graft Substitutes 51
5.1.1.1 Dental Implant Procedures 52
5.1.1.2 Periodontal Procedures 52
5.1.2 Types of Dental Bone Graft Substitutes 52
5.1.2.1 Autografts 52
5.1.2.2 Allografts 53
5.1.2.3 Demineralized Bone Matrix Allografts 54
5.1.2.4 Xenografts 54
5.1.2.5 Synthetics 54
5.1.3 Dental Growth Factor Products 55
5.1.4 Dental Membranes 55
5.1.5 Market Penetration and End Users 56
5.2 MARKET OVERVIEW 57
5.3 TREND ANALYSIS BY SEGMENT 63
5.4 DRIVERS AND LIMITERS 66
5.4.1 Market Drivers 66
5.4.2 Market Limiters 68
5.5 COMPETITIVE MARKET SHARE ANALYSIS 71
5.6 MERGERS AND ACQUISITIONS 79
5.7 COMPANY PROFILES 81
5.7.1 ACE Surgical 81
5.7.2 BioHorizons 82
5.7.3 Dentsply Sirona 83
5.7.4 Geistlich 84
5.7.5 LifeNet Health 85
5.7.6 Medtronic 86
5.7.7 Osteogenics Biomedical 87
5.7.8 Zimmer Biomet 88
5.8 SWOT ANALYSIS 89
5.8.1 ACE Surgical 90
5.8.2 BioHorizons 91
5.8.4 Dentsply Sirona 92
5.8.5 Geistlich 93
5.8.6 LifeNet Health 94
5.8.7 Medtronic 95
5.8.8 Osteogenics Biomedical 96
5.8.9 Zimmer Biomet 97
PROCEDURE NUMBERS 98
6.1 INTRODUCTION 98
6.2 DENTAL BONE GRAFTING PROCEDURES 99
DENTAL BONE GRAFT SUBSTITUTE MARKET 105
7.1 INTRODUCTION 105
7.1.1 Autografts 105
7.1.2 Allografts 106
7.1.2.1 Mineralized Allografts 106
7.1.2.2 Demineralized Bone Matrix 107
7.1.3 Xenografts 107
7.1.4 Synthetics 108
7.2 MARKET OVERVIEW 109
7.3 MARKET ANALYSIS AND FORECAST 114
7.3.1 Total Dental Bone Graft Substitute Market 114
7.3.2 Total Allograft Market 117
7.3.2.1 Mineralized Allograft Market 122
7.3.2.2 Demineralized Bone Matrix Allograft Market 125
7.3.3 Xenograft Market 127
7.3.4 Synthetic Bone Graft Market 130
7.4 UNIT ANALYSIS 132
7.4.1 Bone Graft Substitute Unit Sales by Type 132
7.5 DRIVERS AND LIMITERS 135
7.5.1 Market Drivers 135
7.5.2 Market Limiters 137
7.6 COMPETITIVE MARKET SHARE ANALYSIS 140
DENTAL GROWTH FACTOR MARKET 146
8.1 INTRODUCTION 146
8.2 MARKET OVERVIEW 147
8.3 MARKET ANALYSIS AND FORECAST 151
8.3.1 Emdogain® Market 151
8.3.2 GEM 21S® Market 154
8.3.3 Infuse® Market 157
8.3.4 Osteocel® Market 160
8.4 DRIVERS AND LIMITERS 163
8.4.1 Market Drivers 163
8.4.2 Market Limiters 164
8.5 COMPETITIVE MARKET SHARE ANALYSIS 167
DENTAL BARRIER MEMBRANE MARKET 171
9.1 INTRODUCTION 171
9.2 MARKET OVERVIEW 174
9.3 MARKET ANALYSIS AND FORECAST 179
9.3.1 Total Dental Barrier Membrane Market 179
9.3.2 Resorbable Dental Barrier Membrane Market 182
9.3.3 Non-Resorbable Dental Barrier Membrane Market 184
9.3.3.1 Non-Reinforced Non-Resorbable Dental Barrier Membrane Market 189
9.3.3.2 Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market 191
9.4 UNIT ANALYSIS 193
9.4.1 Dental Barrier Membrane Unit Sales by Size 193
9.4.1.1 Resorbable Dental Barrier Membranes by Size 193
9.4.1.2 Non-Resorbable Dental Barrier Membranes by Size 195
9.4.2 Dental Barrier Membrane Unit Sales by Material 197
9.5 DRIVERS AND LIMITERS 201
9.5.1 Market Drivers 201
9.5.2 Market Limiters 202
9.6 COMPETITIVE MARKET SHARE ANALYSIS 204
ABBREVIATIONS 211

Top US Dental Bone Graft Substitutes Companies Analyzed

  • AB Dental
  • ACE Surgical
  • Benco
  • Bicon
  • BioHorizons
  • BioMimetic
  • Botiss Biomaterials
  • BTI
  • Collagen Matrix
  • Cortex Dental
  • Curasan
  • Datum Dental
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Envista
  • Exactech
  • Geistlich
  • Halma
  • Henry Schein
  • Impladent LTD
  • Implant Direct
  • Inion
  • KaVo Kerr
  • Keystone Dental
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Medtronic
  • MegaGen
  • Nobel Biocare
  • Osteogenics Biomedical
  • Osteohealth
  • Patterson
  • Regentix
  • Salvin
  • Snoasis Medical
  • Straumann Group
  • Tissue Banks
  • Unicare Biomedical
  • Zimmer Biomet

LIST OF CHARTS

Chart 1 1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment,  U.S., 2017 – 2027 2
Chart 1 2: Dental Bone Graft Substitute and Other Biomaterials Market Overview,  U.S., 2020 & 2027 2
Chart 2 1: Multi-Scenario Dental Bone Graft Substitute and Other Biomaterials Market Forecast,  U.S., 2017 – 2027 28
Chart 5 1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, U.S., 2017 – 2027 60
Chart 5 2: Dental Bone Graft Substitute and Other Biomaterials Market Breakdown, U.S., 2020 61
Chart 5 3: Dental Bone Graft Substitute and Other Biomaterials Market Breakdown, U.S., 2027 62
Chart 5 4: Growth Rates by Segment, Dental Bone Graft Substitute and Other Biomaterials Market, U.S., 2018 – 2027 65
Chart 5 5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, U.S., 2020 78
Chart 6 1: Average Volume and Proportion Used with DBGS by Application, U.S., 2017 – 2027 101
Chart 6 2: Bone Graft Volume Share by Application, U.S., 2017 – 2027 104
Chart 7 1: Dental Bone Graft Substitute Market by Segment, U.S., 2017 – 2027 111
Chart 7 2: Dental Bone Graft Substitute Market Breakdown, U.S., 2020 112
Chart 7 3: Dental Bone Graft Substitute Market Breakdown, U.S., 2027 113
Chart 7 4: Total Dental Bone Graft Substitute Market, U.S., 2017 – 2027 116
Chart 7 5: Allograft Market by Segment, U.S., 2017 – 2027 119
Chart 7 6: Total Allograft Market, U.S., 2017 – 2027 121
Chart 7 7: Mineralized Allograft Market, U.S., 2017 – 2027 124
Chart 7 8: Demineralized Bone Matrix Allograft Market, U.S., 2017 – 2027 126
Chart 7 9: Xenograft Market, U.S., 2017 – 2027 129
Chart 7 10: Synthetic Bone Graft Market, U.S., 2017 – 2027 131
Chart 7 11: Bone Graft Substitute Unit Share by Type, U.S., 2017 – 2027 134
Chart 7 12: Leading Competitors, Dental Bone Graft Substitute Market, U.S., 2020 145
Chart 8 1: Dental Growth Factor Market by Segment, U.S., 2017 – 2027 148
Chart 8 2: Dental Growth Factor Market Breakdown, U.S., 2020 149
Chart 8 3: Dental Growth Factor Market Breakdown, U.S., 2027 150
Chart 8 4: Emdogain Market, U.S., 2017 – 2027 153
Chart 8 5: GEM 21S® Market, U.S., 2017 – 2027 156
Chart 8 6: Infuse® Market, U.S., 2017 – 2027 159
Chart 8 7: Osteocel® Market, U.S., 2017 – 2027 162
Chart 9 1: Dental Barrier Membrane Market by Segment, U.S., 2017 – 2027 176
Chart 9 2: Dental Barrier Membrane Market Breakdown, U.S., 2020 177
Chart 9 3: Dental Barrier Membrane Market Breakdown, U.S., 2027 178
Chart 9 4: Total Dental Barrier Membrane Market, U.S., 2017 – 2027 181
Chart 9 5: Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 183
Chart 9 6: Non-Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 188
Chart 9 7: Non-Reinforced, Non-Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 190
Chart 9 8: Titanium-Reinforced, Non-Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 192
Chart 9 9: Resorbable Dental Barrier Membrane Units Sold Breakdown by Size, U.S., 2017 – 2027 194
Chart 9 10: Non-Resorbable Dental Barrier Membrane Units Sold Breakdown by Size, U.S., 2017 – 2027 196
Chart 9 11: Unit Share by Material, Dental Barrier Membrane Market, U.S., 2020 199
Chart 9 12: Unit Share by Source, Xenograft Barrier Membrane Market, U.S., 2020 200
Chart 9 13: Leading Competitors, Dental Barrier Membrane Market, U.S., 2020 210

LIST OF FIGURES

Figure 1 1: Dental Bone Graft Substitute and Other Biomaterials Market Share  Ranking by Segment, U.S., 2020 3
Figure 1 2: Companies Researched in this Report 4
Figure 1 3: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market  by Segment, U.S. 5
Figure 1 4: Recent Events in the Dental Bone Graft Substitute and Other Biomaterials Market, U.S., 2017 – 2020 6
Figure 1 5: Dental Bone Graft Substitute and Other Biomaterials Markets Covered 7
Figure 1 6: Key Report Updates 8
Figure 1 7: Version History 8
Figure 2 1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment,  Best Case Scenario, U.S., 2017 – 2027 (US$M) 25
Figure 2 2: Dental Bone Graft Substitute and Other Biomaterials Market by Segment,  Base Case Scenario, U.S., 2017 – 2027 (US$M) 26
Figure 2 3: Dental Bone Graft Substitute and Other Biomaterials Market by Segment,  Worst Case Scenario, U.S., 2017 – 2027 (US$M) 27
Figure 4 1: Dental Bone Graft Substitute Products by Company (1 of 2) 42
Figure 4 2: Dental Bone Graft Substitute Products by Company (2 of 2) 43
Figure 4 3: Dental Growth Factor Products by Company 44
Figure 4 4: Dental Barrier Membrane Products by Company (1 of 2) 45
Figure 4 5: Dental Barrier Membrane Products by Company (2 of 2) 46
Figure 4 6: Class 2 Device Recall Geistlich BioOss Pen 47
Figure 4 7: Immediate Implant With no Graft, Autogenous Graft or Xenograft 48
Figure 4 8: Healing Dynamics in Human Extraction Sockets Grafted with Bio-Oss Collagen® 48
Figure 4 9: Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation 49
Figure 4 10: The Use of Dental Pulp Tissue as an Autogenous Graft for Ridge Augmentation 49
Figure 4 11: Influence of Bio-Oss Collagen Grafting at Implant Placement on Buccal Bone Volume Regeneration 50
Figure 4 12: Evaluation of Implants Placed Without Bone Grafts in Two Different Sinus Floor Elevation Techniques 50
Figure 5 1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, U.S., 2017 – 2027 (US$M) 59
Figure 5 2: Dental Bone Graft Substitute and Other Biomaterials Market Growth by Segment, U.S., 2017 – 2027 64
Figure 5 3: Drivers and Limiters, Dental Bone Graft Substitute and Other Biomaterials Market, U.S., 2020 70
Figure 5 4: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, U.S., 2020 77
Figure 5 5: SWOT Analysis, ACE Surgical 90
Figure 5 6: SWOT Analysis, BioHorizons 91
Figure 5 7: SWOT Analysis, Dentsply Sirona 92
Figure 5 8: SWOT Analysis, Geistlich 93
Figure 5 9: SWOT Analysis, LifeNet Health 94
Figure 5 10: SWOT Analysis, Medtronic 95
Figure 5 11: SWOT Analysis, Osteogenics Biomedical 96
Figure 5 12: SWOT Analysis, Zimmer Biomet 97
Figure 6 1: Dental Bone Graft Procedures and Penetration Rates, U.S., 2017 – 2027 (1 of 2) 99
Figure 6 2: Dental Bone Graft Procedures and Penetration Rates, U.S., 2017 – 2027 (2 of 2) 100
Figure 6 3: Bone Graft Procedure Numbers and Volume Usage by Application, U.S., 2017 – 2027 (1 of 2) 102
Figure 6 4: Bone Graft Procedure Numbers and Volume Usage by Application, U.S., 2017 – 2027 (2 of 2) 103
Figure 7 1: Dental Bone Graft Substitute Market by Segment, U.S., 2017 – 2027 (US$M) 110
Figure 7 2: Total Dental Bone Graft Substitute Market, U.S., 2017 – 2027 115
Figure 7 3: Allograft Market by Segment, U.S., 2017 – 2027 (US$M) 118
Figure 7 4: Total Allograft Market, U.S., 2017 – 2027 120
Figure 7 5: Mineralized Allograft Market, U.S., 2017 – 2027 123
Figure 7 6: Demineralized Bone Matrix Allograft Market, U.S., 2017 – 2027 125
Figure 7 7: Xenograft Market, U.S., 2017 – 2027 128
Figure 7 8: Synthetic Bone Graft Market, U.S., 2017 – 2027 130
Figure 7 9: Bone Graft Substitute Units Sold by Type, U.S., 2017 – 2027 133
Figure 7 10: Drivers and Limiters, Dental Bone Graft Substitute Market, U.S., 2020 139
Figure 7 11: Leading Competitors, Dental Bone Graft Substitute Market, U.S., 2020 144
Figure 8 1: Dental Growth Factor Market by Segment, U.S., 2017 – 2027 (US$M) 147
Figure 8 2: Emdogain® Market, U.S., 2017 – 2027 152
Figure 8 3: GEM 21S® Market, U.S., 2017 – 2027 155
Figure 8 4: Infuse® Market, U.S., 2017 – 2027 158
Figure 8 5: Osteocel® Market, U.S., 2017 – 2027 161
Figure 8 6: Drivers and Limiters, Dental Growth Factor Market, U.S., 2020 166
Figure 8 7: Leading Competitors, Dental Growth Factor Market, U.S., 2020 169
Figure 9 1: Dental Barrier Membrane Market by Segment, U.S., 2017 – 2027 (US$M) 175
Figure 9 2: Total Dental Barrier Membrane Market, U.S., 2017 – 2027 180
Figure 9 3: Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 (US$M) 182
Figure 9 4: Non-Resorbable Dental Barrier Membrane Market by Segment, U.S., 2017 – 2027 185
Chart 9 5: Non-Resorbable Dental Barrier Membrane Market by Segment, U.S., 2017 – 2027 186
Figure 9 6: Non-Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 187
Figure 9 7: Non-Reinforced, Non-Resorbable Dental Barrier Membrane Market, U.S., 2017 – 2027 189
Figure 9 8: Titanium-Reinforced, Non-Resorbable Dental Barrier Membrane Market,  U.S., 2017 – 2027 191
Figure 9 9: Resorbable Dental Barrier Membrane Unit Share Breakdown by Size, U.S., 2017 – 2027 193
Figure 9 10: Non-Resorbable Dental Barrier Membrane Unit Share Breakdown by Size,  U.S., 2017 – 2027 195
Figure 9 11: Unit Share by Type, Dental Barrier Membrane Market, U.S., 2020 198
Figure 9 12: Unit Share by Material, Dental Barrier Membrane Market, U.S., 2020 198
Figure 9 13: Unit Share by Source, Xenograft Barrier Membrane Market, U.S., 2020 198
Figure 9 14: Drivers and Limiters, Dental Barrier Membrane Market, U.S., 2020 203
Figure 9 15: Leading Competitors, Dental Barrier Membrane Market, U.S., 2020 209

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology